(Q40013710)

English

Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.

scientific article published on March 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

peptide nucleic acid

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Hitoshi Miyazawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Tomoaki Tanaka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yoshiaki Nagai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Masaru Matsuoka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Huqun

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Akihisa Sutani

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kiyoshi Udagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jialing Zhang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yoshitake Murayama

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Nobuyuki Koyama

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kenji Ikebuchi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Makoto Nagata

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Minoru Kanazawa

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Toshihiro Nukiwa

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Seiichi Takenoshita

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kunihiko Kobayashi

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Koichi Hagiwara

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

99

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

595-600

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18271876%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00706.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40013710&oldid=1964221343"